Assess whether to report a refusal for shy bladder after a collector who

SITUATION Specimen Validity work in a company transitioning to oral fluid now turns on to report a refusal because a collector who skipped the bluing agent put split-specimen B bottle request timeline in play. DOT program-design consultant should say what split-specimen B bottle request timeline proves.

DECISION DOT program-design consultant in a company transitioning to oral fluid must choose Accept the result / Reject on custody / Recollect / Hold using split-specimen B bottle request timeline after a collector who skipped the bluing agent.

HYPOTHESES TO TEST 1. Split-specimen B bottle request timeline reads as Accept the result once a collector who skipped the bluing agent is lined up to the same Forensic Drug Testing population. 2. Split-specimen B bottle request timeline is closer to Reject on custody after a collector who skipped the bluing agent; Accept the result would over-claim this Specimen Validity extract. 3. Recollect is still live in split-specimen B bottle request timeline for DOT program-design consultant in a company transitioning to oral fluid. 4. Split-specimen B bottle request timeline is missing the fact DOT program-design consultant needs after a collector who skipped the bluing agent; stop this Forensic Drug Testing close.

ANALYSIS REQUIRED 1. Check MRO notes and cutoffs against the protocol a company transitioning to oral fluid claims to run. 2. Walk chain of custody, collection site, and validity flags in split-specimen B bottle request timeline after a collector who skipped the bluing agent. 3. Name the step DOT program-design consultant cannot reconstruct from split-specimen B bottle request timeline. 4. For this Forensic Drug Testing Specimen Validity file, read split-specimen B bottle request timeline against a collector who skipped the bluing agent and write the one fact that would move to report a refusal for DOT program-design consultant.

RECOMMENDATION Choose Accept the result / Reject on custody / Recollect / Hold on this Forensic Drug Testing / Specimen Validity packet (split-specimen B bottle request timeline after a collector who skipped the bluing agent). If split-specimen B bottle request timeline cannot force a Forensic Drug Testing label under Specimen Validity, stop. Do not invent missing evidence a company transitioning to oral fluid does not have.

COMMAND RETURNS - Bottom-line Forensic Drug Testing option on to report a refusal, then the evidence in split-specimen B bottle request timeline, then the action for DOT program-design consultant - Hypothesis scorecard against split-specimen B bottle request timeline: supported / rejected / untestable - Named option among Accept the result, Reject on custody, Recollect and the fact that kills the others - Owner and next date for DOT program-design consultant in a company transitioning to oral fluid